Immunomodulatory activity of the aqueous extract from rhizome of Smilax glabra in the later phase of adjuvant-induced arthritis in rats

Journal of Ethnopharmacology

Volumn 85, Issue 1, 2003, Pages 53-59

  Jiang, Jieyun ^a   Xu, Qiang ^b  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

Adjuvant arthritis; Immunomodulatory activity; Macrophages; Rhizoma Smilacis Glabrae; T lymphocytes

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CONCANAVALIN A; CYCLOPHOSPHAMIDE; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PICRYL CHLORIDE; PLANT EXTRACT; PREDNISOLONE; SMILAX GLABRA EXTRACT; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; DOSE RESPONSE; DOWN REGULATION; DRUG MECHANISM; FEMALE; FOOT PAD; IMMUNOMODULATION; INFLAMMATION; MALE; NONHUMAN; PERITONEUM MACROPHAGE; RAT; REGULATORY MECHANISM; RHIZOME; SMILAX GLABRA; SPLEEN CELL; T LYMPHOCYTE; WEIGHT GAIN;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ARTHRITIS, EXPERIMENTAL; CD4-CD8 RATIO; CELL DIVISION; CELLS, CULTURED; CYCLOPHOSPHAMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INTERLEUKIN-1; INTERLEUKIN-2; MACROPHAGES, PERITONEAL; MALE; NITRIC OXIDE; PHYTOTHERAPY; PLANT EXTRACTS; PREDNISOLONE; RATS; RATS, SPRAGUE-DAWLEY; RHIZOME; SMILAX; SPLEEN; T-LYMPHOCYTES;

EID: 0037358308     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-8741(02)00340-9     Document Type: Article

References (31)

1. Arend W.P., Dayer J.M. Cytokine, antagonist and rheumatoid arthritis. Arthritis Rheumatoid. 33:1990;305-315.
2. Baimgartner W.A., Beck F.W., Lorber A., Peason C.M., Whitehouse W. Adjuvant disease in rats: biochemical criteria for distinguishing several phases of inflammation and arthritis. Proceedings in Society of Experimental Biological Medicine. 145:1974;625-630.
3. Beutler B., Cerami A. The biology of cachectin/TNF-α - a primary mediator of the host response. Annual Review of Immunology. 7:1989;625-655.
4. Billingham, M.E.J., Davies, E.G., 1979. Experimental models of arthritis in animals as screening tests for drugs to treat arthritis in man. In: Vane, J.R., Ferreira, S.H. (Eds.), Anti-inflammatory Drugs: Handbook of Experimental Pharmacology. Berlin: Springer 50, pp. 108-144.
5. Bogdan C., Paik J., Vodovotz Y., Nathan C.F. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-β and interlukin-10. Journal of Biological Chemistry. 267:1992;23301-23308.
6. Cohen I.R. Autoimmunity to chaperonins in the pathogenesis of arthritis and diabetes. Annual Review of Pharmacology. 9:1991;567-589.
7. Ding A.H., Nathan C.F. Trace levels of bacterial lipopolysaccharide prevent interon-γ or tumor necrosis factor-α from enhancing mouse peritoneal macrophage respiratory burst capacity. Journal of Immunology. 139:1987;1971-1977.
8. Ding A.H., Nathan C.F., Stuehr D.J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. Journal of Immunology. 141:1988;2407-2412.
9. Du Z.Y., Li X.Y. Cytokine and nitric oxide production by rat microglia stimulated with lipopolysaccharides in vitro. Acta Pharmacology Sinica. 19:1998;257-260.
10. Farrell A.G., Blake D.R., Palmer R.M. Increased concentrations of nitrite in synovial fluide and serum sample suggest increased nitric oxide synthesis in rheumatic diseases. Annual Rheumatoid Disease. 47:1988;768-771.
11. Firestein G.S., Tsai V., Zvaifler N.J. Cellular immunity in the joints of patients with rheumatoid arthritis and other forms of chronic synovitis. Clinic Rheumatoid Disease. 13:1987;191-213.
12. Foresta P., Ruggiero V., Albertoni C., Pacello L., Leoni B., Martelli E. In vitro activation of murine peritoneal exudate cells and peritoneal macrophages by ST789. International Journal of Immunopharmacology. 14:1992;1061-1068.
13. Green L.M., Reade J.L., Ware C.F. Rapid colorimetric assay for cell viability: Application to the quantitation of cytotoxic and growth inhibitory lymphokines. Journal of Immunological Methods. 70:1984;257-268.
14. Guerne P.A., Zuraw B.L., Vaughan J.H., Carson D.A., Lotz M. Synovium as a source of interleukin 6 in vitro. Journal of Clinic Investigation. 83:1989;585-592.
15. Hom J.T., Bendele A.M., Carlson D.G. In vivo administration with IL-1 accelerates the development of collagen-induced arthritis in mice. Journal of Immunology. 141:1988;834-841.
16. Ialenti A., Moncada S., Di Rosa M. Modulation of adjuvant arthritis by endogenous nitric oxide. British Journal of Pharmacology. 110:1993;701-706.
17. Jasin H.E., Dingle J.T. Human mononuclear cell factors mediate cartrix degradation through chondrocyte activation. Journal of Clinic Investigation. 68:1981;571-581.
18. Jiang J.Y., Wu F.H., Lu J.F., Lu Z.H., Xu Q. Anti-inflammatory activity of the aqueous extract from Rhizoma Smilacis Glabrae. Pharmacological Research. 36(4):1997;309-314.
19. Kolb H., Kiesel U., Kroncke K.D., Kolb-Bachofen V. Suppression of low dose strptozotocin induced diabetes in mice by administration of a nitric oxide sythase inhibitor. Life Sciences. 49:1991;213-217.
20. Kroncke K.D., Kolb-Bachofen V., Berschick B., Burkart Y., Kolb H. Activated macrophages kill pancreatic syngeneic islet cells via arginine-dependent nitric oxide generation. Biochemistry and Biophysics Research Communications. 175:1991;752-758.
21. Kung P.C., Goldstein G., Reinherz E.L., Schlossman S.F. Monoclonal antibodies defining distinctive human T cell surface antigens. Science. 206:1979;347-349.
22. Liew F.Y., Li Y., Moss D., Parkinson C., Rogers M.V., Moncada S. Resistance to Leishmania major infection correlates with the induction of nitric oxide synthase in murine macrophages. Europe Journal of Immunology. 21:1991;3009-3014.
23. Miossec P., Kashiwado T., Ziff M. Inhibitors of interleukin-2 in rheumatoid synovial fluid. Arthritis Rheumatoid. 30:1987;121-129.
24. Nathan C.F., Hibbs J.B. Jr. Role of nitric oxide synthesis in macrophage antimicrobial activity. Current Opinion in Immunology. 3:1991;65-70.
25. Newbold B.B. Chemotherapy of arthritis induced in rats by injection of mycobacterial adjuvant. British Journal of Pharmacology. 21:1963;127-136.
26. Sakane T., Takada S., Murakawa Y., Kotani H., Honda M., Ueda Y. Analysis of suppressor T cell function in patients with rheumatoid arthritis: effects in production of and responsiveness to concanavalin A-induced suppressor T cell. Journal of Immunology. 129:1982;1972-1977.
27. Stuehr D.J., Gross S.S., Sakuma I., Levi R., Nathan C.F. Activated murine macrophages serete a metabolite of arginine with the bioactivity of endothelium-derived relaxing factor and the chemical reactivity of nitric oxide. Journal of Experimental Medicine. 169:1989;1011-1020.
28. Thorbecke G.J., Shah R., Leu C.H., Kuruvilia A.P., Hardison A.M., Palladino M.A. Involvement of endogenous tumor necrosis factor-α and transforming growth factor-β during induction of collagen type II arthritis in mice. Immunology. 89:1992;7375-7379.
29. Walz D.T., DrMartino M.J., Misher A. Adjuvant-induced arthritis in rats. II. Drug effects on physiologic biochemical and immunologic parameters. Journal of Pharmacology Experiment and Therapeutics. 178:1971;223-231.
30. Xu Q., Wang R., Xu L.H., Jiang J.Y. Effects of Rhizoma Smilacis Glabrae cellular and humoral immune responses. Chinese Journal of Immunology. 9:1993;39-42.
31. Xu Q., Wang R., Jiang J.Y., Wu F.H., Lu J.F., Tan P.K., Xu L.H. Liver injury model in mice induced by a cellular immunologic mechanism - Delayed-type hypersensitivity-induced liver injury to picryl chloride and phenotype of effector cells. Cellular Immunology. 167:1996;38-43.